Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Regulation of 1,25-dihydroxyvitamin D sub 3 receptors in human promyelocytic leukemic cells, HL-60

Thesis/Dissertation ·
OSTI ID:6529400

The regulation of 1,25-dihydroxyvitamin D{sub 3} (1,25-(OH){sub 2}D{sub 3}) was investigated in human target cells using human promyelocytic leukemic cell line, HL-60, as a model system. Receptors for 1,25-(OH){sub 2}D{sub 3} in intact HL-60 cells were saturated with ({sup 3}H)1,25-(OH){sub 2}D{sub 3} within 1 h after hormone addition. Continuous exposure of cells to hormone for longer times resulted in an apparent up-regulation which was maximal between 8-16 h after hormone addition. This was followed by an apparent down-regulation which could be observed by 24 h. The immunoblotting assays indicated that an up-regulation resulted from actual increases in receptor protein and a down-regulation from a decrease in receptor protein and a loss of binding ability of receptors. The monocytic inducers of HL-60, 1,25-(OH){sub 2}D{sub 3} and phorbol 12-myristate 13-acetate (PMA) could regulate the level of receptors. However, the granulocytic inducers of HL-60 cells, retinoic acid and dimethyl sulfoxide failed to regulate the specific ({sup 3}H)1,25-(OH){sub 2}D{sub 3} binding.

Research Organization:
Wisconsin Univ., Madison, WI (USA)
OSTI ID:
6529400
Country of Publication:
United States
Language:
English